We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNXM
3376
DELISTED
CNX Midstream Partners LP
CNXM
$582K ﹤0.01%
35,370
+9,159
+35% +$132K
IMGN
3377
DELISTED
Immunogen Inc
IMGN
$580K ﹤0.01%
113,615
+14,174
+14% +$48.1K
QCRH icon
3378
QCR Holdings
QCRH
$1.69B
$578K ﹤0.01%
13,173
-1,357
-9% -$55.4K
SXI icon
3379
Standex International
SXI
$3.59B
$578K ﹤0.01%
7,284
-3,667
-33% -$279K
CHS
3380
DELISTED
Chicos FAS, Inc.
CHS
$577K ﹤0.01%
151,603
+22,844
+18% +$87.8K
EWL icon
3381
iShares MSCI Switzerland ETF
EWL
$2.19B
$576K ﹤0.01%
14,171
-11,217
-44% -$433K
NBR icon
3382
CALL
Nabors Industries
NBR
$1.27B
$576K ﹤0.01%
+4,000
New +$421K
LBAI
3383
DELISTED
Lakeland Bancorp Inc
LBAI
$576K ﹤0.01%
33,104
-3,041
-8% -$50.1K
SILK
3384
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$575K ﹤0.01%
14,260
-13,090
-48% -$458K
NSTG
3385
DELISTED
NanoString Technologies, Inc.
NSTG
$575K ﹤0.01%
20,681
-16,519
-44% -$401K
MBUU icon
3386
Malibu Boats
MBUU
$541M
$574K ﹤0.01%
14,020
-2,042
-13% -$73.8K
ATRS
3387
DELISTED
Antares Pharma, Inc.
ATRS
$574K ﹤0.01%
122,202
+36,561
+43% +$150K
GABC icon
3388
German American Bancorp
GABC
$1.91B
$572K ﹤0.01%
16,062
-818
-5% -$27.4K
HLIT icon
3389
Harmonic Inc
HLIT
$1.25B
$572K ﹤0.01%
73,372
+9,692
+15% +$72.4K
OSW icon
3390
OneSpaWorld
OSW
$2.61B
$572K ﹤0.01%
33,976
+23,500
+224% +$370K
HPE icon
3391
CALL
Hewlett Packard
HPE
$63.4B
$571K ﹤0.01%
36,000
GTS
3392
DELISTED
Triple-S Management Corporation
GTS
$571K ﹤0.01%
30,931
-4,966
-14% -$84.6K
COHU icon
3393
Cohu
COHU
$2.26B
$569K ﹤0.01%
24,956
-11,112
-31% -$200K
HSII
3394
DELISTED
Heidrick & Struggles
HSII
$569K ﹤0.01%
17,489
+367
+2% +$10.8K
CMRE icon
3395
Costamare
CMRE
$1.88B
$568K ﹤0.01%
59,641
+47,840
+405% +$382K
NXTC icon
3396
NextCure
NXTC
$16.8M
$568K ﹤0.01%
+841
New +$422K
RVNC
3397
DELISTED
Revance Therapeutics, Inc.
RVNC
$568K ﹤0.01%
35,012
+7,967
+29% +$124K
LTRPA
3398
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$568K ﹤0.01%
77,366
+26,084
+51% +$210K
CTRA
3399
CALL
DELISTED
Coterra Energy
CTRA
$566K ﹤0.01%
+32,500
New +$565K
NVEC icon
3400
NVE Corp
NVEC
$562M
$562K ﹤0.01%
7,864
-469
-6% -$30.6K

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.